WELCOME AND KEYNOTE SESSIONS
DIA JapanBarbara Lopez Kunz
Global Chief Executive
DIATatsuo Kurokawa, PhD
Chair, DIA Advisory Council of Japan
Professor, Division of Drug Development & Regulatory Sciences
Faculty of Pharmacy, Keio University
13:40-13:50 OPENING REMARKS
PROGRAM CHAIRHiroshi Watanabe, MD, PhD
Deparment of Clinical Pharmacology & Therapeutics
Hamamatsu University School of Medicine
13:50-14:00 GLOBAL DIA AWARDS PRESENTATION
PRESENTERBarbara Lopez Kunz
Global Chief Executive
AWARD WINNERSJunichi Nishino, MSc, RPh
Head, Regulatory Operation & Prescribing Information Group
Drug Regulatory Affairs Department
Regulatory Affairs & Quality Assurance Division
Novartis Pharma K.K.Hidetoshi Shuto
Senior Fellow, Corporate Research & Development Div.
Nitto Denko CorporationAtsushi Tsukamoto, PhD
Senior Director, Global Project Management
Daiichi Sankyo Co., Ltd.
14:00-14:05 PROGRAM INSTRUCTIONS
14:20-15:10 KEYNOTE SPEECH 1
Director, Evaluation and Licensing Division
Pharmaceutical and Food Safety Bureau
Ministry of Health, Labour and Welfare
Keynote speech 1 of 2014 DIA Japan Annual Meeting will be presented by Dr. Hiroo Imura, President of Foundation for Biomedical Research and Innovation (FBRI). Dr. Imura successively held number of important positions such as President of University of Kyoto, Member of Council for Science, Technology and Innovation and since 2014 as President of FBRI has been leading the largest medical cluster in Japan promoting practical application of advanced medical science such as regenerative medicine.
Further as Chairman of General Assembly of The Japan Association of Medical Science 2015 Kansai, Dr. Imura is challenging to new initiatives which will enhance innovation in medical science and medical treatment to be participated by all stakeholders including various professional fields, generations and patients and families.
It is a great opportunity that we can listen to Dr. Imura’s future vision who is really leading various significant initiatives in medical society now which transcend boundaries.
Hiroo Imura, MD, PhD
Foundation for Biomedical Research and Innovation
15:10-16:00 KEYNOTE SPEECH 2
Representative Director, DIA Japan
We plan to invite an astronaut from Japan Aerospace Exploration Agency (JAXA) as a keynote speaker for the session.
Please note that this keynote speech may be cancelled due to training schedule of the astronauts.
16:00-16:30 COFFEE BREAK
16:30-18:00 SPECIAL SESSION
Tatsuo Kurokawa, PhD
Professor, Division of Drug Development and Regulatory Sciences
Faculty of Pharmacy
Ten years have passed since PMDA was established and the agency continues to develop various strategies for aiming to be one of the world’s leading regulatory agencies, releasing PMDA International Vision and Roadmap For this session, Dr. Tatsuya Kondo, Chief Executive of PMDA will provide updates on their international activities and cooperation. We will also invite top executives of overseas regulatory agencies as speakers to discuss future visions for international collaboration.
Tatsuya Kondo, MD, PhD
Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)
Luca Pani, MD
Italian Medicines Agency (AIFA)
18:15-20:00 NETWORKING RECEPTION
Please join us at the Opening Networking Reception in the Reception Hall for an excellent opportunity to see your old friends and to make new acquaintances, while visiting the booths of exhibiting companies and academic affiliations.